Leukemic Presentation of ALK+ Anaplastic Large Cell Lymphoma With a Novel Partner, Poly(A) Binding Protein Cytoplasmic 1 (PABPC1), Responding to Single-Agent Crizotinib

Haematologica - Italy
doi 10.3324/haematol.2018.215103
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Leukemic Phase of ALK-positive Anaplastic Large Cell Lymphoma

Blood
BiochemistryImmunologyCell BiologyHematology
2013English

ALK-negative Anaplastic Large Cell Lymphoma

2020English

A Conserved Role for Cytoplasmic Poly(A)-Binding Protein 1 (PABPC1) in Nonsense-Mediated mRNA Decay

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2007English

Three Years Sustained Complete Remission Achieved in a Primary Refractory ALK-positive Anaplastic T Large Cell Lymphoma Treated With Crizotinib

Rare Tumors
OncologyHistology
2016English

Unusual Clinical Presentation of Anaplastic Large Cell Lymphoma

Autopsy and Case Reports
2014English

ALK-positive Anaplastic Large Cell Lymphoma With Soft Tissue Involvement in a Young Woman

OncoTargets and Therapy
OncologyPharmacology
2016English

Secondary CNS Involvement of ALK-negative Anaplastic Large Cell Lymphoma

American Journal of Hematology
Hematology
2017English

A Rare and Isolated Presentation of Primary Cutaneous Anaplastic Large Cell Lymphoma

Acta Dermatovenerologica Alpina, Panonica et Adriatica
DermatologyMedicineInfectious Diseases
2018English

48. Mediastinal ALK-positive Anaplastic Large Cell Lymphoma in a 12-Year Old Male

Pathology
Forensic MedicinePathology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy